1. Home
  2. ASMB vs EHGO Comparison

ASMB vs EHGO Comparison

Compare ASMB & EHGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • EHGO
  • Stock Information
  • Founded
  • ASMB 2005
  • EHGO 2015
  • Country
  • ASMB United States
  • EHGO China
  • Employees
  • ASMB 65
  • EHGO N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • EHGO
  • Sector
  • ASMB Health Care
  • EHGO
  • Exchange
  • ASMB Nasdaq
  • EHGO NYSE
  • Market Cap
  • ASMB 84.5M
  • EHGO 90.4M
  • IPO Year
  • ASMB 2010
  • EHGO 2024
  • Fundamental
  • Price
  • ASMB $13.42
  • EHGO $1.08
  • Analyst Decision
  • ASMB Buy
  • EHGO
  • Analyst Count
  • ASMB 2
  • EHGO 0
  • Target Price
  • ASMB $35.00
  • EHGO N/A
  • AVG Volume (30 Days)
  • ASMB 22.6K
  • EHGO 556.8K
  • Earning Date
  • ASMB 03-27-2025
  • EHGO 02-15-2025
  • Dividend Yield
  • ASMB N/A
  • EHGO N/A
  • EPS Growth
  • ASMB N/A
  • EHGO N/A
  • EPS
  • ASMB N/A
  • EHGO 0.00
  • Revenue
  • ASMB $28,326,000.00
  • EHGO $16,963,957.00
  • Revenue This Year
  • ASMB $282.16
  • EHGO N/A
  • Revenue Next Year
  • ASMB N/A
  • EHGO N/A
  • P/E Ratio
  • ASMB N/A
  • EHGO $2,933.26
  • Revenue Growth
  • ASMB N/A
  • EHGO N/A
  • 52 Week Low
  • ASMB $9.84
  • EHGO $0.91
  • 52 Week High
  • ASMB $19.93
  • EHGO $5.50
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 40.25
  • EHGO N/A
  • Support Level
  • ASMB $13.60
  • EHGO N/A
  • Resistance Level
  • ASMB $14.25
  • EHGO N/A
  • Average True Range (ATR)
  • ASMB 0.58
  • EHGO 0.00
  • MACD
  • ASMB -0.05
  • EHGO 0.00
  • Stochastic Oscillator
  • ASMB 5.93
  • EHGO 0.00

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About EHGO ESHALLGO INC

Eshallgo Inc. focuses on two distinct market sectors: office supply sale and leasing, and after-sale maintenance and repair. It is an authorized distributor of brands of office equipment, including HP, Epson, Xerox, Sharp, Toshiba, Konica, Kyocera, and other brands.

Share on Social Networks: